Valantine Hannah bought BBIO
February 27, 2026 · Form 4 insider transaction
Valantine Hannah bought 25,484 shares of BridgeBio Pharma, Inc. at $48.45 per share, a transaction worth $1.23M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,484
Price
$48.45
Total value
$1.23M
InsiderValantine Hannah
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after32,949
OwnershipDirect
10b5-1 planNo
AmendedNo